EYPT(EyePoint, Inc.) · 财务报表

EYPT(EyePoint, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$36.94M$41.40M$46.02M$43.27M$31.37M
毛利润—————
营业利润−$55.28M−$99.64M−$75.07M−$145.85M−$243.43M
净利润−$58.42M−$102.25M−$70.80M−$130.87M−$231.96M
经营现金流−$50.10M−$65.00M$1.88M−$126.23M−$240.11M
自由现金流−$50.25M−$67.16M−$1.61M−$130.28M−$243.39M
摊薄每股收益$-2.03$-2.74$-1.82$-2320.00$-3170.00

EyePoint, Inc. EYPT